Trials / Completed
CompletedNCT02972216
Post-marketing Surveillance Study of Docetaxel-Based Chemotherapy
A Post-marketing Surveillance Study to Evaluate the Effectiveness and Safety of Docetaxel-Based Chemotherapy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- Yung Shin Pharm. Ind. Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
A Post-marketing Surveillance Study to Evaluate the Effectiveness and Safety of Docetaxel-Based Chemotherapy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nolbaxol | |
| DRUG | Taxotere | |
| DRUG | cisplatin |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2016-10-01
- First posted
- 2016-11-23
- Last updated
- 2016-11-23
Source: ClinicalTrials.gov record NCT02972216. Inclusion in this directory is not an endorsement.